img

Global Bone Densitometer Market Size By Technology (Axial Bone Densitometry (DXA), Peripheral Bone Densitometry (pDXA), and Quantitative Ultrasound (QUS)), By End-User (Hospitals, Specialty Clinics, and Imaging Centers), By Geographic Scope And Forecast


Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report

Publisher : MIR | Format : PDF&Excel

Global Bone Densitometer Market Size By Technology (Axial Bone Densitometry (DXA), Peripheral Bone Densitometry (pDXA), and Quantitative Ultrasound (QUS)), By End-User (Hospitals, Specialty Clinics, and Imaging Centers), By Geographic Scope And Forecast

Bone Densitometer Market Size And Forecast

Bone Densitometer Market size was valued at USD 284.8 Million in 2024 and is projected to reach USD 398.48 Million by 2031, growing at a CAGR of 4.73 % from 2024 to 2031.

  • A bone densitometer is a specialized medical device used to measure bone mineral density (BMD), reflecting the amount of mineral content (primarily calcium) per unit volume of bone.
  • It employs dual-energy X-ray absorptiometry (DXA), emitting two low-dose X-ray beams with differing energy levels. Bone tissue absorbs these beams differently than soft tissue, allowing for precise BMD measurement.
  • Bone densitometers are primarily utilized for, diagnosing osteoporosis, characterized by low BMD and increased fracture risk, monitoring the efficacy of osteoporosis treatments, and assessing fracture risk in individuals with bone-weakening conditions.
  • During a Bone Densitometry scan, the patient lies on a table while the scanner arm passes over the specific body part being examined. The procedure is non-invasive and painless, taking about 10 to 30 minutes depending on the number of sites scanned.
  • Common measurement sites for Bone Densitometry include the spine (lumbar vertebrae), hip (femoral neck and total hip), and forearm (radius). These sites are chosen because they are prone to fractures in osteoporosis and provide accurate readings of bone density.
  • Bone Densitometry is commonly used for postmenopausal women, who are at higher risk for osteoporosis, older adults to assess general bone health and fracture risk, and individuals with certain medical conditions or on medications that affect bone density.

Global Bone Densitometer Market Dynamics

The key market dynamics that are shaping the global bone densitometer market include

Key Market Drivers

  • Growing Osteoporosis Prevalence Osteoporosis is a serious health issue, especially for the elderly population. The need for bone densitometers for early diagnosis and monitoring is being driven by the rising prevalence of osteoporosis and related bone ailments as the world’s population ages.
  • Technological Developments The accuracy and efficiency of bone density measurements are improved by developments in bone densitometry technology, such as the creation of portable, high-resolution instruments. The healthcare industry is growing because of these technological improvements, which draw in providers and motivate them to spend money on new equipment.
  • Growing Awareness and Screening Programmes The need for bone densitometry screening is driven by growing awareness of bone health and the significance of early bone problem detection. The use of bone densitometers for preventive healthcare is facilitated by government programmes, health campaigns, and improved patient education.
  • Growing Older Population Osteoporosis and osteopenia are two bone-related illnesses that are more common in the ageing population. The need for bone densitometry tools to evaluate and manage bone health in the senior population is rising in tandem with the worldwide ageing population.
  • Growing Healthcare Expenditure As healthcare costs rise, especially in developing nations, medical facilities can purchase more sophisticated technology, such as bone densitometers. Market expansion is facilitated by the growing healthcare infrastructure and the ease of access to healthcare services.
  • Diagnostic Significance in Chronic Illnesses Bone density evaluations are essential for detecting osteoporosis as well as evaluating the health of the bones in long-term ailments such as diabetes, rheumatoid arthritis, and chronic kidney disease. Market expansion is fueled by the growing use of bone densitometry in the diagnosis and treatment of a range of chronic illnesses.
  • Technological Integration in Healthcare By integrating bone densitometry equipment with picture archiving and communication systems (PACS) and electronic health records (EHRs), healthcare institutions can improve patient care and workflow efficiency. The use of bone densitometers in medical facilities and diagnostic labs is encouraged by this integration.
  • Encouraging Insurance Coverage and Reimbursement Policies These Policies for bone densitometry examinations incentivize healthcare providers to deliver these treatments and allocate funds towards purchasing bone densitometry equipment, thereby driving market expansion.

Key Challenges

  • High Cost The purchase, upkeep, and use of bone densitometers can be costly. Smaller healthcare facilities or those in developing countries may find it prohibitive to operate due to this high cost, which would restrict market penetration.
  • Limited Reimbursement Regulations Reimbursement regulations for bone density testing may be uneven or limited in various regions, which may impact patient affordability and consequently lower demand for bone densitometers.
  • Technological Difficulties Although bone densitometry technology has come a long way, adoption rates may still be impacted by issues with accuracy, dependability, and usability.
  • Rivalry from Alternative Technologies There may be rivalry in the market for bone densitometry from other imaging modalities or diagnostic procedures that offer comparable or additional information. Examples of these procedures include CT scans and ultrasounds.
  • Regulatory Obstacles Tight regulations pertaining to medical equipment may impede the release of upgraded or new bone densitometer models, hence impeding market expansion.
  • Limited Access and Awareness There may be a decreased demand for bone densitometers in specific areas or among certain demographic groups due to a lack of knowledge about osteoporosis and the significance of bone density testing.
  • Economic Factors Declines or spikes in healthcare costs can affect people’s and healthcare facilities’ purchasing power, which can result in a decrease in the amount of money invested in bone densitometry equipment.
  • Patient Concerns The demand for bone densitometers may be impacted by patients’ reluctance to undertake bone density testing because they are worried about radiation exposure or discomfort during the operation.

Key Trends

  • Rising Geriatric Population and Increased Osteoporosis Risk An aging population globally leads to a higher prevalence of osteoporosis, driving the demand for bone densitometers for diagnosis and monitoring.
  • Technological Advancements and Multi-Modality Imaging Advancements in DEXA technology, integration with digital detectors, and exploration of multi-modality imaging with peripheral quantitative CT (pQCT) are increasing accuracy, and efficiency, and offering more comprehensive bone health assessment.
  • Growing Adoption in Early Diagnosis and Disease ManagementEarly detection and intervention for osteoporosis are crucial. Bone densitometers are becoming increasingly used for preventive care and monitoring treatment response.
  • Focus on Portable and Home-Based Bone Densitometers Portable and home-based bone densitometers are gaining traction due to their convenience and potential for wider patient access, particularly for at-risk populations.
  • Increasing Awareness and Screening Programs Growing public awareness about osteoporosis and initiatives for bone health screening programs are positively impacting the market.
  • Reimbursement Policies and Cost-Effectiveness Analysis Reimbursement policies and cost-effectiveness analyses are crucial factors influencing hospital and clinic decisions regarding bone densitometer adoption.
  • Emerging Markets and Regional Growth Potential The Bone Densitometer Market is expected to see significant growth in emerging economies like China and India due to their aging populations and rising healthcare expenditure.
  • Data Security and Integration with Electronic Health Records Focus on data security and seamless integration of bone densitometer data with electronic health records is becoming increasingly important.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Bone Densitometer Market Regional Analysis

Here is a more detailed regional analysis of the global bone densitometer market

North America

  • North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period.
  • North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies.
  • The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.
  • North America is home to many of the world’s main manufacturers of bone densitometers, which contributes to the region’s dominant position. To preserve market leadership, these organizations prioritize innovation and product development.
  • In North America, there is a significant emphasis on preventative healthcare and osteoporosis screening programs, which drives up demand for Bone Densitometers for early detection and treatment.
  • A well-established regulatory system protects product safety and efficacy, giving healthcare practitioners and patients confidence in using Bone Densitometer technology.
  • North America is a key location for medical technology research and development, which promotes ongoing innovation in Bone Densitometer systems. This innovation fuels market growth and ensures the region’s dominance.
  • The region’s significant healthcare expenditure supports advanced diagnostic technology such as bone densitometers, assuring widespread availability in clinical settings.
  • North America has a well-established healthcare system, with many healthcare facilities outfitted with advanced diagnostic equipment, including Bone Densitometers.

Asia Pacific

  • Asia Pacific is anticipated to be the fastest-growing region in the bone densitometer market. Economic development, an aging population, and an increased frequency of osteoporosis and related disorders are all contributing to Asia Pacific’s rapid growth in healthcare spending.
  • Countries such as China, India, and Japan are experiencing rapid growth in healthcare infrastructure and medical device usage, including Bone Densitometers.
  • Governments in Asia Pacific are increasingly focusing on improving healthcare accessibility and quality, including investments in innovative medical equipment like bone densitometers.
  • Healthcare practitioners and consumers are becoming more aware of the importance of bone health and early detection of osteoporosis, which is driving up demand for Bone Densitometer devices.
  • Rapid urbanization and economic expansion in Asia Pacific have resulted in enhanced healthcare infrastructure and higher adoption rates of modern medical technologies such as bone densitometers.
  • The region’s aging population, together with higher life expectancy, is pushing up demand for Bone Densitometers to effectively manage osteoporosis and related disorders.
  • Governments across the Asia Pacific are investing in healthcare infrastructure development and programs to improve healthcare access, including the purchase of diagnostic equipment such as bone densitometers.
  • Local and foreign manufacturers are producing technologically improved Bone Densitometer systems designed specifically for Asia Pacific markets, increasing acceptance rates.

Global Bone Densitometer MarketSegmentation Analysis

The Global Bone Densitometer Market is segmented based on Technology, End-User, And Geography.

Bone Densitometer Market, By Technology

  • Axial Bone Densitometry (DXA)
  • Peripheral Bone Densitometry (pDXA)
  • Quantitative Ultrasound (QUS)

Based on Technology, the market is bifurcated into Axial Bone Densitometry (DXA), Peripheral Bone Densitometry (pDXA), and Quantitative Ultrasound (QUS). Axial Bone Densitometry (DXA) dominates the Bone Densitometer market because to its high precision and dependability in detecting bone mineral density at important areas such as the spine and hip, which are particularly vulnerable to osteoporotic fractures. Its broad use in clinical settings for osteoporosis diagnosis and fracture risk assessment, together with its capacity to give complete and exact data, strengthens its position as the industry leader. Furthermore, ongoing technical improvements and endorsements from major health organizations increase its use and desirability among healthcare providers.

Bone Densitometer Market, By End User

  • Hospitals
  • Specialty Clinics
  • Imaging Centers

Based on End Users, the market is bifurcated into Hospitals, Specialty Clinics, and Imaging Centers. Hospitals lead the Bone Densitometer market because of their enormous infrastructure and capacity to provide comprehensive diagnostic services, such as advanced imaging technologies. They are frequently outfitted with cutting-edge bone densitometry technology, such as DXA machines, which are critical for detecting and monitoring osteoporosis and other bone-related diseases. The large number of patients in hospitals, together with their ability to handle complex situations and provide integrated treatment, ensures a consistent need for bone densitometry services. Furthermore, the presence of specialist departments and competent healthcare personnel improves the reliability and accuracy of bone density evaluations, bolstering hospitals’ market-leading position.

Bone Densitometer Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, the Global Bone Densitometer Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period, owing to several variables. North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies. The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

Key Players

The “Global Bone Densitometer Market” study report will provide valuable insight emphasizing the global market. The major players in the market are GE Healthcare, Hologic Inc., DMS Imaging, Swissray International Inc., Osteometer Meditech Inc., Echolight S.p.A., Medonica Co. Ltd, Hitachi Ltd., Siemens Healthineers, and Canon Medical Systems Corporation

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In March 2023, GE Healthcare announced the launch of an updated version of their Lunar iDXA system, featuring enhanced software capabilities to improve diagnostic accuracy and patient throughput.
  • In April 2022, Hologic Inc. expanded its product line with the introduction of the Horizon DXA system, designed to offer advanced imaging capabilities for comprehensive bone health assessment​​.
  • In February 2023, DMS Imaging unveiled a new series of portable bone densitometers aimed at increasing accessibility in rural and remote healthcare settings, enhancing the ability to diagnose and treat osteoporosis.
  • In January 2023, Swissray International Inc. launched their new Digital Radiography (DR) solutions that integrate bone densitometry capabilities, streamlining diagnostic processes in clinical settings.

Report Scope

REPORT ATTRIBUTESDETAILS
STUDY PERIOD

2021-2031

BASE YEAR

2024

FORECAST PERIOD

2024-2031

HISTORICAL PERIOD

2021-2023

UNIT

Value (USD Million)

KEY COMPANIES PROFILED

GE Healthcare, Hologic Inc., DMS Imaging, Swissray International Inc., Osteometer Meditech Inc., Echolight S.p.A., Medonica Co. Ltd, Hitachi Ltd., Siemens Healthineers, and Canon Medical Systems Corporation

SEGMENTS COVERED

By Technology, By End-User, And By Geography

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indic

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )